Diagnostic and clinical relevance of HBV mutations

Laboratory Medicine

Volumn 42, Issue 8, 2011, Pages 488-496

  Horvat, Rebecca T ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Clinical chemistry; Immunology; Virology

Indexed keywords

DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS HEPATITIS B VACCINE; DOUBLE STRANDED DNA; HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS A HEPATITIS B VACCINE; HEPATITIS B VACCINE; IMMUNOGLOBULIN M; MUTANT PROTEIN; RECOMBINANT HEPATITIS B VACCINE;

ANTIVIRAL THERAPY; ARTICLE; DISEASE ASSOCIATION; DISEASE COURSE; DNA REPLICATION; DRUG RESISTANCE; HEPATITIS B; HEPATITIS B VIRUS; IMMUNE RESPONSE; IMMUNITY; IMMUNOCOMPROMISED PATIENT; NONHUMAN; REVERSE TRANSCRIPTION; RNA TRANSCRIPTION; SACCHAROMYCES CEREVISIAE; SURFACE PROPERTY; VACCINE FAILURE; VIRUS INFECTION; VIRUS MUTATION; VIRUS REPLICATION;

HEPATITIS B VIRUS;

EID: 79961146811     PISSN: 00075027     EISSN: 19437730     Source Type: Journal    
DOI: 10.1309/LM7SF4QZMEG5LVPN     Document Type: Article

References (63)

1. Sorrell MF, Belongia EA, Costa J, et al. National Institutes of Health Consensus Development Conference Statement: Management of hepatitis B. Ann Intern Med. 2009;150:104-110.
2. Shepard CW, Simard EP, Finelli L, et al. Hepatitis B virus infection: Epidemiology and vaccination. Epidemiol Rev. 2006;28:112-125.
3. Degertekin B, Lok AS. Update on viral hepatitis: 2008. Curr Opin Gastroenterol. 2009;25:180-185.
4. Mahoney FJ. Update on diagnosis, management, and prevention of hepatitis B virus infection. Clin Microbiol Rev. 1999;12:351-366.
5. Lin CL, Kao JH, Chen BF, et al. Application of hepatitis B virus genotyping and phylogenetic analysis in intrafamilial transmission of hepatitis B virus. Clin Infect Dis. 2005;41:1576-1581.
6. Coleman PF. Detecting hepatitis B surface antigen mutants. Emerg Infect Dis. 2006;12:198-203.
7. Gerlich WH, Bremer C, Saniewski M, et al. Occult hepatitis B virus infection: Detection and significance. Dig Dis. 2010;28:116-125.
8. Alter HJ, Blumberg BS. Further studies on a "new" human isoprecipitin system (Australia antigen). Blood. 1966;27:297-309.
9. Blumberg BS, Alter HJ, Visnich S. A "new" antigen in leukemia sera. JAMA. 1965;191:541-546.
10. Chisari FV. Hepatitis B virus biology and pathogenesis. Mol Genet Med. 1992;2:67-104.
11. Liang TJ. Hepatitis B: The virus and disease. Hepatology. 2009;49(5 suppl):S13-S21.
12. Günther S. Genetic variation in HBV infection: Genotypes and mutants. J Clin Virol. 2006;36(suppl 1):S3-S11.
13. Harrison TJ. Hepatitis B virus: Molecular virology and common mutants. Semin Liver Dis. 2006;26:87-96.
14. Yim HJ, Lok AS. Natural history of chronic hepatitis B virus infection: What we knew in 1981 and what we know in 2005. Hepatology. 2006;43(2 suppl 1):S173-S181.
15. Bertoletti A, Gehring AJ. The immune response during hepatitis B virus infection. J Gen Virol. 2006;87:1439-1449.
16. Krajden M, McNabb G, Petric M. The laboratory diagnosis of hepatitis B virus. Can J Infect Dis Med Microbiol. 2005;16:65-72.
17. Lok AS, McMahon BJ. Chronic hepatitis B: Update 2009. Hepatology. 2009;50:661-662.
18. McMahon BJ. The natural history of chronic hepatitis B virus infection. Hepatology. 2009;49(5 suppl):S45-S55.
19. Carman WF, Thursz M, Hadziyannis S, et al. Hepatitis B e antigen negative chronic active hepatitis: Hepatitis B virus core mutations occur predominantly in known antigenic determinants. J Viral Hepat. 1995;2:77-84.
20. Bowden S. Serological and molecular diagnosis. Semin Liver Dis. 2006;26:97-103.
21. Centers for Disease Control and Prevention. Recommendations for preventing transmission of human immunodeficiency virus and hepatitis B virus to patients during exposure-prone invasive procedures. MMWR Recomm Rep. 1991;40:1-9.
22. Valsamakis A. Molecular testing in the diagnosis and management of chronic hepatitis B. Clin Microbiol Rev. 2007;20:426-439.
23. Andersson KL, Chung RT. Monitoring during and after antiviral therapy for hepatitis B. Hepatology. 2009;49(5 suppl):S166-S173.
24. Wursthorn K, Manns MP, Wedemeyer H. Natural history: The importance of viral load, liver damage and HCC. Best Pract Res Clin Gastroenterol. 2008;22:1063-1079.
25. Krajden M, Minor J, Cork L, et al. Multi-measurement method comparison of three commercial hepatitis B virus DNA quantification assays. J Viral Hepat. 1998;5:415-422.
26. Heermann KH, Gerlich WH, Chudy M, et al. Quantitative detection of hepatitis B virus DNA in two international reference plasma preparations. Eurohep Pathobiology Group. J Clin Microbiol. 1999;37:68-73.
27. Doherty R, Garland S, Wright M, et al. Effectiveness of a bivalent Haemophilus influenzae type B-hepatitis B vaccine in preventing hepatitis B virus infection among children born to hepatitis B e antigen-positive carrier mothers. Pediatr Infect Dis J. 2009;28:777-781.
28. Lavanchy D. Viral hepatitis: Global goals for vaccination. J Clin Virol. 2009 Jul 3. [Epub ahead of print].
29. Daniels D, Grytdal S, Wasley A, et al. Surveillance for acute viral hepatitis-United States, 2007. MMWR Surveill Summ. 2009;58:1-27.
30. Dentinger CM, McMahon BJ, Butler JC, et al. Persistence of antibody to hepatitis B and protection from disease among Alaska natives immunized at birth. Pediatr Infect Dis J. 2005;24:786-792.
31. McMahon BJ, Bruden DL, Petersen KM, et al. Antibody levels and protection after hepatitis B vaccination: Results of a 15-year follow-up. Ann Intern Med. 2005;142:333-341.
32. Carman WF, Zanetti AR, Karayiannis P, et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet. 1990;336:325-329.
33. Gerlich WH. Breakthrough of hepatitis B virus escape mutants after vaccination and virus reactivation. J Clin Virol. 2006;36(suppl 1):S18-S22.
34. Kajiwara E, Tanaka Y, Ohashi T, et al. Hepatitis B caused by a hepatitis B surface antigen escape mutant. J Gastroenterol. 2008;43:243-247.
35. Zheng X, Weinberger KM, Gehrke R, et al. Mutant hepatitis B virus surface antigens (HBsAg) are immunogenic but may have a changed specificity. Virology. 2004;329:454-464.
36. Gerlich WH, Glebe D, Schüttler CG. Deficiencies in the standardization and sensitivity of diagnostic tests for hepatitis B virus. J Viral Hepat. 2007;14(suppl 1):16-21.
37. Mizuochi T, Okada Y, Umemori K, et al. Evaluation of 10 commercial diagnostic kits for in vitro expressed hepatitis B virus (HBV) surface antigens encoded by HBV of genotypes A to H. J Virol Methods. 2006;136:254-256.
38. Osiowy C. Detection of HBsAg mutants. J Med Virol. 2006;78(suppl 1):S48-S51.
39. Hollinger FB. Hepatitis B virus genetic diversity and its impact on diagnostic assays. J Viral Hepat. 2007;14(suppl 1):11-15.
40. Petit MA, Maillard P, Capel F, et al. Immunochemical structure of the hepatitis B surface antigen vaccine-II. Analysis of antibody responses in human sera against the envelope proteins. Mol Immunol. 1986;23:511-523.
41. Echevarría JM, Avellón A. Improved detection of natural hepatitis B virus surface antigen (HBsAg) mutants by a new version of the VITROS HBsAg assay. J Med Virol. 2008;80:598-602.
42. Thakur V, Kazim SN, Guptan RC, et al. Transmission of G145R mutant of HBV to an unrelated contact. J Med Virol. 2005;76:40-46.
43. Song BC, Kim SH, Kim H, et al. Prevalence of naturally occurring surface antigen variants of hepatitis B virus in Korean patients infected chronically. J Med Virol. 2005;76:194-202.
44. Hsu CW, Yeh CT, Chang ML, et al. Identification of a hepatitis B virus S gene mutant in lamivudine-treated patients experiencing HBsAg seroclearance. Gastroenterology. 2007;132:543-550.
45. Tabor E. Infections by hepatitis B surface antigen gene mutants in Europe and North America. J Med Virol. 2006;78 (suppl 1):S43-S47.
46. Cao GW. Clinical relevance and public health significance of hepatitis B virus genomic variations. World J Gastroenterol. 2009;15:5761-5769.
47. Lada O, Benhamou Y, Poynard T, et al. Coexistence of hepatitis B surface antigen (HBs Ag) and anti-HBs antibodies in chronic hepatitis B virus carriers: Influence of "a" determinant variants. J Virol. 2006;80:2968-2975.
48. Roth WK, Weber M, Petersen D, et al. NAT for HBV and anti-HBc testing increase blood safety. Transfusion. 2002;42:869-875.
49. Seitz R, Heiden M. Quality and safety in blood supply in 2010. Transfus Med Hemother. 2010;37:112-117.
50. Alter HJ, Klein HG. The hazards of blood transfusion in historical perspective. Blood. 2008;112:2617-2626.
51. Mu SC, Lin YM, Jow GM, et al. Occult hepatitis B virus infection in hepatitis B vaccinated children in Taiwan. J Hepatol. 2009;50:264-272.
52. Kusumoto K, Yatsuhashi H, Nakao R, et al. Detection of HBV core promoter and precore mutations helps distinguish flares of chronic hepatitis from acute hepatitis B. J Gastroenterol Hepatol. 2008;23:790-793.
53. Tong S, Kim KH, Chante C, et al. Hepatitis B virus e antigen variants. Int J Med Sci. 2005;2:2-7.
54. Chotiyaputta W, Lok AS. Hepatitis B virus variants. Nat Rev Gastroenterol Hepatol. 2009;6:453-462.
55. Liu S, Zhang H, Gu C, et al. Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: A meta-analysis. J Natl Cancer Inst. 2009;101:1066-1082.
56. Nguyen MH, Keeffe EB. Chronic hepatitis B: Early viral suppression and long-term outcomes of therapy with oral nucleos(t)ides. J Viral Hepat. 2009;16:149-155.
57. Pawlotsky JM, Dusheiko G, Hatzakis A, et al. Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: Recommendations for a standardized approach. Gastroenterology. 2008;134:405-415.
58. Rotman Y, Brown TA, Hoofnagle JH. Evaluation of the patient with hepatitis B. Hepatology. 2009;49(5 suppl):S22-S27.
59. Zoulim F, Buti M, Lok AS. Antiviral-resistant hepatitis B virus: Can we prevent this monster from growing? J Viral Hepat. 2007;14(suppl 1):29-36.
60. Pastor R, Habersetzer F, Fafi-Kremer S, et al. Hepatitis B virus mutations potentially conferring adefovir/tenofovir resistance in treatment-naive patients. World J Gastroenterol. 2009;15:753-755.
61. Akarsu M, Sengonul A, Tankurt E, et al. YMDD motif variants in inactive hepatitis B carriers detected by Inno-Lipa HBV DR assay. J Gastroenterol Hepatol. 2006;21:1783-1788.
62. Han Y, Huang LH, Liu CM, et al. Characterization of hepatitis B virus reverse transcriptase sequences in Chinese treatment naive patients. J Gastroenterol Hepatol. 2009;24:1417-1423.
63. Torresi J. The virological and clinical significance of mutations in the overlapping envelope and polymerase genes of hepatitis B virus. J Clin Virol. 2002;25:97-106.